AU8196791A - Creation of Inventions and Patents with Artificial Intelligence

AU8196791A – Methods for detecting spinal muscular atrophy type i and types ii/iii and marker therefor
– Google Patents

AU8196791A – Methods for detecting spinal muscular atrophy type i and types ii/iii and marker therefor
– Google Patents
Methods for detecting spinal muscular atrophy type i and types ii/iii and marker therefor

Info

Publication number
AU8196791A

AU8196791A
AU81967/91A
AU8196791A
AU8196791A
AU 8196791 A
AU8196791 A
AU 8196791A
AU 81967/91 A
AU81967/91 A
AU 81967/91A
AU 8196791 A
AU8196791 A
AU 8196791A
AU 8196791 A
AU8196791 A
AU 8196791A
Authority
AU
Australia
Prior art keywords
iii
types
methods
muscular atrophy
spinal muscular
Prior art date
1990-06-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Application number
AU81967/91A
Inventor
Conrad Gilliam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Columbia University of New York

Original Assignee
Columbia University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1990-06-27
Filing date
1991-06-27
Publication date
1992-01-23

1991-06-27
Application filed by Columbia University of New York
filed
Critical
Columbia University of New York

1992-01-23
Publication of AU8196791A
publication
Critical
patent/AU8196791A/en

Status
Abandoned
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING

C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions

C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

C—CHEMISTRY; METALLURGY

C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING

C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions

C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

C12Q1/6813—Hybridisation assays

C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism

C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]

C—CHEMISTRY; METALLURGY

C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING

C12Q2600/00—Oligonucleotides characterized by their use

C12Q2600/112—Disease subtyping, staging or classification

C—CHEMISTRY; METALLURGY

C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING

C12Q2600/00—Oligonucleotides characterized by their use

C12Q2600/156—Polymorphic or mutational markers

AU81967/91A
1990-06-27
1991-06-27
Methods for detecting spinal muscular atrophy type i and types ii/iii and marker therefor

Abandoned

AU8196791A
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

US54440590A

1990-06-27
1990-06-27

US544405

1990-06-27

Publications (1)

Publication Number
Publication Date

AU8196791A
true

AU8196791A
(en)

1992-01-23

Family
ID=24172039
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU81967/91A
Abandoned

AU8196791A
(en)

1990-06-27
1991-06-27
Methods for detecting spinal muscular atrophy type i and types ii/iii and marker therefor

Country Status (2)

Country
Link

AU
(1)

AU8196791A
(en)

WO
(1)

WO1992000386A1
(en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

FR2720757B1
(en)

1994-06-03
1996-08-02
Inst Nat Sante Rech Med

Method and probes for the detection of markers linked to the locus of infantile spinal muscular atrophies.

AU697985B2
(en)

1994-10-18
1998-10-22
Research Development Corporation Of Japan
Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy

EP0708178A1
(en)

1994-10-19
1996-04-24
Institut National De La Sante Et De La Recherche Medicale (Inserm)
Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy

EP0711833B1
(en)

1994-10-19
2005-08-03
Institut National De La Sante Et De La Recherche Medicale (Inserm)
Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy

CA2817256A1
(en)

2010-11-12
2012-05-18
The General Hospital Corporation
Polycomb-associated non-coding rnas

US9920317B2
(en)

2010-11-12
2018-03-20
The General Hospital Corporation
Polycomb-associated non-coding RNAs

US10837014B2
(en)

2012-05-16
2020-11-17
Translate Bio Ma, Inc.
Compositions and methods for modulating SMN gene family expression

SG11201407483YA
(en)

2012-05-16
2014-12-30
Rana Therapeutics Inc
Compositions and methods for modulating smn gene family expression

CA2873779A1
(en)

2012-05-16
2013-11-21
Rana Therapeutics Inc.
Compositions and methods for modulating mecp2 expression

JP2016534035A
(en)

2013-10-04
2016-11-04
ラナセラピューティクスインコーポレイテッド

Compositions and methods for treating amyotrophic lateral sclerosis

EP3212824A4
(en)

2014-10-30
2018-08-08
The General Hospital Corporation
Methods for modulating atrx-dependent gene repression

US10900036B2
(en)

2015-03-17
2021-01-26
The General Hospital Corporation
RNA interactome of polycomb repressive complex 1 (PRC1)

Family Cites Families (1)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

CA1323553C
(en)

1987-11-03
1993-10-26
Timothy George Helentjaris
Method and device for improved restriction fragment length polymorphism analysis

1991

1991-06-27
AU
AU81967/91A
patent/AU8196791A/en
not_active
Abandoned

1991-06-27
WO
PCT/US1991/004605
patent/WO1992000386A1/en
unknown

Also Published As

Publication number
Publication date

WO1992000386A1
(en)

1992-01-09

Contact information